Endothelial Microparticles: Pathogenic or Passive Players?

Scientific Updates Sponsored by Endothelix Inc

Vascul Pharmacol. 2016 Jun

Endothelial Microparticles:
Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?

McCarthy EM1, Wilkinson FL2, Parker B3, Alexander MY4.

Abstract
Endothelial microparticles (EMPs) are released into the circulation from activated endothelial cells and may therefore, reflect disease severity, vascular and endothelial dysfunction, that could influence disease pathogenesis via autocrine/paracrine signalling. The exact function of EMPs in rheumatic disease remains unknown, and this has initiated research to elucidate EMP composition and function, which may be determined by the mode of endothelial activation and the micro environment.
To date, EMPs are thought to play a role in angiogenesis, thrombosis and inflammation by transferring specific proteins and microRNAs (miRs) to target cells. Here, we review the mechanisms underlying the generation and composition of EMPs and the clinical and experimental studies describing the involvement of EMPs in rheumatic diseases, since we have previously shown 
endothelial dysfunction and an elevated risk of cardiovascular disease are characteristics in systemic lupus erythematosus. 

.
****************************************************

 Evaluate Endothelial Function with VENDYS Digital Thermal Monitoring of
Vascu
lar Reactivity

Cartoon guy_captions2_Sept2014-1.jpg

new-slideshow-image-patientdoc2.JPG 

 

 Natural Course of Atherosclerosis (structural .png

An innovative, inexpensive, noninvasive office-based test to enhance your practice and improve patient care.

easy.JPG   

Endothelix_HomePageSlider_1.png

Leave a Reply

LATEST SCIENTIFIC UPDATES

Enhance your patient care with the new office-based vascular function test.

Sign Up for our Webinar Series

Why Should We Measure Endothelial Function?